Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» ATTR amyloidosis
ATTR amyloidosis
Alnylam's next-gen ATTR amyloidosis drug hits goals in phase 3, teeing up approval filing
Alnylam's next-gen ATTR amyloidosis drug hits goals in phase 3, teeing up approval filing
Fierce Biotech
clinical trials
Alnylam
ATTR amyloidosis
vutrisiran
Flag link:
Pfizer's Vyndaqel franchise, buoyed by diagnoses, is poised for 'a decisive beat': analyst
Pfizer's Vyndaqel franchise, buoyed by diagnoses, is poised for 'a decisive beat': analyst
Fierce Pharma
Pfizer
tafamidis
FDA
Vyndaqel
Alnylam
Ionis
ATTR amyloidosis
Flag link:
Alnylam Pharmaceuticals Is Launched and Ready for More
Alnylam Pharmaceuticals Is Launched and Ready for More
Motley Fool
Alnylam
ATTR amyloidosis
Onpattro
Flag link:
6 Things Alnylam Investors Need to Know About Pfizer's Next Blockbuster Drug
6 Things Alnylam Investors Need to Know About Pfizer's Next Blockbuster Drug
Motley Fool
Alnylam
Onpattro
Pfizer
ATTR amyloidosis
tafamidis
Vyndaqel
Flag link:
EU Advisory Group Backs Orphan Drug Designation for Alnylam's ALN-TTRsc02 for ATTR Amyloidosis
EU Advisory Group Backs Orphan Drug Designation for Alnylam's ALN-TTRsc02 for ATTR Amyloidosis
CP Wire
Alnylam
EMA
orphan drugs
ALN-TTRsc02
ATTR amyloidosis
Flag link:
